Bill > HB388

This bill establishes a new provision in Ohio state law that provides reimbursement to state employees and elected officials for certain GLP-1 drugs (glucagon-like peptide-1 receptor agonists) used for chronic weight management. Specifically, the bill allows state employees with a body mass index (BMI) of 30 or higher to receive financial assistance for purchasing FDA-approved weight management drugs through manufacturer direct-to-consumer programs. Reimbursements are limited to a 24-month period, with a maximum of $500 in the first year and up to $250 in the second year. To qualify for a subsequent 24-month reimbursement period, an employee must demonstrate that they have regained at least 20% of the weight they previously lost. The bill requires the director of administrative services to establish rules for implementing these reimbursements and includes provisions to prevent reimbursement for compounded versions of the drugs. The legislation aims to support state employees in managing obesity-related health challenges by providing financial assistance for specific weight management medications.

Government Affairs

https://www.legislature.ohio.gov/legislation/136/hb388